Articles

Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia

Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden;Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden;Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece
MLL Munich Leukemia Laboratory, Munich, Germany
Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece
Division of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy
Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Department of Haematology, Royal Bournemouth Hospital, UK
Hemopathology Unit, Hospital Clinic, Barcelona, Spain
Cancer Genomics, Academic Unit of Cancer Sciences, Cancer Research UK Centre and Experimental Cancer Medicine Centre, Faculty of Medicine, University of Southampton, UK
Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic
Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece;Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Hemopathology Unit, Hospital Clinic, Barcelona, Spain
Hematology Department, Hospital Clinic, Barcelona, Spain
Cancer Genomics, Academic Unit of Cancer Sciences, Cancer Research UK Centre and Experimental Cancer Medicine Centre, Faculty of Medicine, University of Southampton, UK
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
Department of Medicine, Solna, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden
Lund University and Hospital Department of Hematology, Lund Stem Cell Center, Sweden
Department of Hemato-Oncology, Belfast City Hospital, UK
Department of Hemato-Oncology, Belfast City Hospital, UK
Cancer Genomics, Academic Unit of Cancer Sciences, Cancer Research UK Centre and Experimental Cancer Medicine Centre, Faculty of Medicine, University of Southampton, UK
Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
Hematology Department, Nikea General Hospital, Pireaus, Greece
Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic
Department of Haematology, Royal Bournemouth Hospital, UK
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Hemopathology Unit, Hospital Clinic, Barcelona, Spain;Department of Pathology, University of Barcelona, Spain
MLL Munich Leukemia Laboratory, Munich, Germany
Division of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden;Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece
Vol. 104 No. 2 (2019): February, 2019 https://doi.org/10.3324/haematol.2018.195032